NERV / Minerva Neurosciences, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Minerva Neurosciences, Inc.
US ˙ NasdaqCM ˙ US6033802058

Ausstehende Aktien 46,588,709 shares
Insider-Aktien5.401.084 shares
Insider-Besitz11,59 %
Insider gesamt32
Insider-Stimmungswert

Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.

Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.

Aktualisierungshäufigkeit: Täglich

Sehen Sie sich die Top-Optionen der Insider an, die eine Liste der Unternehmen mit der höchsten Insiderakkumulation enthalten.

Führungskräfte-Stimmungswert

Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.

Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.

Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.

Aktualisierungshäufigkeit: Täglich

Sehen Sie sich die Insiders Top-Auswahl an, die eine Liste der Unternehmen mit der höchsten Insider-Stimmung enthalten.

Wichtige Insider-Kennzahlen

Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.

Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).

Nettoanzahl der Insider, die kaufen (Rang)

0 ( )
4965 out of 10916

Die Nettoanzahl der Insiderkäufe ist die Gesamtzahl der Insiderkäufe abzüglich der Gesamtzahl der Insiderverkäufe in den letzten 90 Tagen. Der Perzentilrang wird hier angezeigt (Bereich von 0 bis 100%).

Prozent des Streubesitzes von Insidern gekauft (Rang)

0.000% ( )
5150 out of 10752

Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.

Diagramm zum Insiderhandel

Minerva Neurosciences, Inc. Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.

Kennzahlen zu Insiderlisten und Rentabilität

Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.

See our leaderboard of most profitable insider traders.

Insider Durchschnittlicher Gewinn (%) Aktien
in Besitz
Split
Angepasst
Frederick W Ahlholm SVP, CFO and Secretary - [O] 17.518 17.518
Plc Barclays 10% Owner - [10%] 196.800 196.800
Boehringer Ingelheim International Gmbh 10% Owner - [10%] 2.550.000 2.550.000
Marc D Beer Director - [D] 50.000 6.250
Care Capital III LLC 10% Owner - [10%] 1.662.592 207.824
Care Capital Investments III L.P. 10% Owner - [10%] 1.662.592 207.824
Care Capital Offshore Investments III LP 10% Owner - [10%] 1.662.592 207.824
William F Doyle Director - [D] 26.111 3.264
Michael Davidson Chief Medical Officer - [O] 0 0
Rubertis Francesco De Director, 10% Owner - [D] [10%] 4.690.906 586.363
Insider Durchschnittlicher Gewinn (%) Aktien
in Besitz
Split
Angepasst
Hans Peter Hasler Director - [D] 10.000 1.250
Jeryl L Hilleman Director - [D] 1.000 125
Venture Associates III Ltd Index 10% Owner - [10%] 3.899.189 487.399
Venture Associates IV Ltd Index 10% Owner - [10%] 3.899.189 487.399
Venture Associates V Ltd Index 10% Owner - [10%] 3.899.189 487.399
& Johnson Johnson 10% Owner - [10%] 0 0
Johnson & Johnson Innovation - JJDC, Inc. 10% Owner - [10%] 0 0
David Kupfer Director - [D] 163.553 20.444
Fouzia Laghrissi-Thode Director - [D] 0 0
Levine Mark S. SVP,General Counsel & Sec. - [O] 0 0
Remy Luthringer CEO, Director - [D] [O] 184.819 184.819
Insider Durchschnittlicher Gewinn (%) Aktien
in Besitz
Split
Angepasst
Michele Ollier Director, 10% Owner - [D] [10%] 4.690.906 586.363
Lorenzo Pellegrini Director, 10% Owner - [D] [10%] 3.883.212 485.402
Geoff Race President - [O] 51.324 51.324
Reilly Joseph H. SVP & Chief Operating Officer - [O] 31.747 3.968
Russell Richard E. President - [O] 33.770 4.221
Jay Saoud 100.000
Devin Whittemore Smith 85.000
Heek G Jan Van Director - [D] 20.333 2.542
Nico Vandervelpen Director - [D] 0 0
Coelho Rogerio Vivaldi President and CEO, Director - [D] [O] 41.667 5.208
(Jersey) SLP Yucca 10% Owner - [10%] 3.899.189 487.399

Report errors via our new Insider Auditing Tool

Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse

In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in NERV / Minerva Neurosciences, Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .

Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.

Handelsdatum Insider Gemeldete
Aktien
Gemeldeter
Preis
Angepasste
Aktien
Angepasster
Preis
Kostenbasis Tage bis
Max
Preis bei
Max
Max
Gewinn ($)
Max Rendite (%)
2020-09-10 VAN HEEK G JAN 7.000 2,9700 875 23,7600 20.790 78 4.0100 -17.281 -83,12
2019-06-27 DOYLE WILLIAM F 3.500 5,5000 438 44,0000 19.250
2019-06-26 HILLEMAN JERYL L 1.000 5,2500 125 42,0000 5.250
2019-06-26 Kupfer David 10.000 5,5500 1.250 44,4000 55.500
2019-06-26 VAN HEEK G JAN 10.000 5,3700 1.250 42,9600 53.700
2019-06-26 HASLER HANS PETER 10.000 5,6000 1.250 44,8000 56.000
2018-12-20 DOYLE WILLIAM F 2.000 6,5000 250 52,0000 13.000
2018-12-11 DOYLE WILLIAM F 4.000 7,9500 500 63,6000 31.800
2018-12-10 DOYLE WILLIAM F 2.000 8,0000 250 64,0000 16.000

Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.

NERV / Minerva Neurosciences, Inc. Insider Trades
Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse

In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in NERV / Minerva Neurosciences, Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .

Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.

Handelsdatum Insider Gemeldete
Aktien
Gemeldeter
Preis
Angepasste
Aktien
Angepasster
Preis
Kostenbasis Tage bis
Min
Preis bei
Min
Max Verlust
Vermieden($)
Max Verlust
Vermieden(%)
2023-05-02 Luthringer Remy 3.641 3,7600 3.641 3,7600 13.690 365 2.3300 -5.206 -38,03
2023-05-01 Luthringer Remy 23.753 3,8500 23.753 3,8500 91.449
2023-05-01 Race Geoff 22.082 3,8500 22.082 3,8500 85.016
2023-05-01 Ahlholm Frederick W 3.580 4,4800 3.580 4,4800 16.038
2021-12-01 Kupfer David 55.635 0,8800 6.954 7,0400 48.959
2020-12-16 Reilly Joseph H. 3.228 2,6400 404 21,1200 8.522
2020-12-16 Race Geoff 6.190 2,6400 774 21,1200 16.342
2020-12-16 Luthringer Remy 1.300 2,6400 162 21,1200 3.432
2020-12-16 Ahlholm Frederick W 1.845 2,6400 231 21,1200 4.871

Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.

NERV / Minerva Neurosciences, Inc. Insider Trades
Transaktionshistorie

Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.

Datei
Datum
Handel
Datum
Form Insider Ticker Wertpapier-Titel Code 10b5-1 Direkt Ausführung
Preis
Einheit
Preis
Eimheiten
Verändert
Wert
Geändert (1K)
Verbleibende
Optionen
Verbleibende
Aktien
2023-07-07 3 BOEHRINGER INGELHEIM INTERNATIONAL GMBH NERV Common Stock D 1.275.000
2023-05-02 2023-05-02 4 Luthringer Remy NERV Common Stock S - Sale D 3,7600 -3.641 -14 68.994
2023-05-02 2023-05-01 4 Luthringer Remy NERV Common Stock S - Sale D 3,8500 -23.753 -91 72.635
2023-05-02 2023-04-28 4 Luthringer Remy NERV Common Stock A - Award D 88.077 96.388
2023-05-02 2023-05-01 4 Race Geoff NERV Common Stock S - Sale D 3,8500 -22.082 -85 51.324
2023-05-02 2023-04-28 4 Race Geoff NERV Common Stock A - Award D 46.987 73.406
2023-05-02 2023-05-01 4 Ahlholm Frederick W NERV Common Stock S - Sale D 4,4800 -3.580 -16 17.518
2023-05-02 2023-04-28 4 Ahlholm Frederick W NERV Common Stock A - Award D 19.843 21.098
2022-08-10 3 BARCLAYS PLC By Barclays Capital Inc. NERV Common Stock, $0.0001 par value per share I 196.800
2022-08-10 3 BARCLAYS PLC By Barclays Bank PLC NERV Common Stock, $0.0001 par value per share I 408.430
2022-02-18 2022-02-16 4 Ahlholm Frederick W NERV Employee Stock Option (right to buy) A - Award D 0,79 180.000 180.000
2022-02-18 2022-02-16 4 Luthringer Remy NERV Employee Stock Option (right to buy) A - Award D 0,79 505.000 505.000
2022-02-18 2022-02-16 4 Race Geoff NERV Employee Stock Option (right to buy) A - Award D 0,79 200.000 200.000
2021-12-03 2021-12-01 4 Kupfer David NERV Common Stock S - Sale D 0,8800 -55.635 -49 163.553
2021-06-16 2021-06-11 4 HASLER HANS PETER NERV Stock Option (right to buy) A - Award D 2,90 20.000 20.000
2021-06-15 2021-06-11 4 DOYLE WILLIAM F NERV Stock Option (right to buy) A - Award D 2,90 40.000 40.000
2021-06-15 2021-06-11 4 VAN HEEK G JAN NERV Stock Option (right to buy) A - Award D 2,90 20.000 20.000
2021-06-15 2021-06-11 4 HILLEMAN JERYL L NERV Stock Option (right to buy) A - Award D 2,90 20.000 20.000
2021-06-15 2021-06-11 4 Laghrissi-Thode Fouzia NERV Stock Option (right to buy) A - Award D 2,90 20.000 20.000
2021-06-15 2021-06-11 4 Kupfer David NERV Stock Option (right to buy) A - Award D 2,90 20.000 20.000
2020-12-16 2020-12-16 4 Reilly Joseph H. NERV Common Stock S - Sale D 2,6400 -3.228 -9 31.747
2020-12-16 2020-12-14 4 Reilly Joseph H. NERV Restricted Stock Unit M - Exercise D -8.750 0
2020-12-16 2020-12-14 4 Reilly Joseph H. NERV Common Stock M - Exercise D 8.750 34.975
2020-12-16 2020-12-16 4 Race Geoff NERV Common Stock S - Sale D 2,6400 -6.190 -16 211.354
2020-12-16 2020-12-14 4 Race Geoff NERV Restricted Stock Unit M - Exercise D -12.500 0
2020-12-16 2020-12-14 4 Race Geoff NERV Common Stock M - Exercise D 12.500 217.544
2020-12-16 2020-12-16 4 Luthringer Remy NERV Common Stock S - Sale D 2,6400 -1.300 -3 66.490
2020-12-16 2020-12-14 4 Luthringer Remy NERV Restricted Stock Unit M - Exercise D -18.750 0
2020-12-16 2020-12-14 4 Luthringer Remy NERV Common Stock M - Exercise D 18.750 67.790
2020-12-16 2020-12-16 4 Ahlholm Frederick W NERV Common Stock S - Sale D 2,6400 -1.845 -5 10.039
2020-12-16 2020-12-14 4 Ahlholm Frederick W NERV Restricted Stock Unit M - Exercise D -5.000 0
2020-12-16 2020-12-14 4 Ahlholm Frederick W NERV Common Stock M - Exercise D 5.000 11.884
2020-10-14 2020-10-13 4 Luthringer Remy NERV Employee Stock Option (right to buy) A - Award D 3,50 200.000 200.000
2020-10-14 2020-10-13 4 Race Geoff NERV Employee Stock Option (right to buy) A - Award D 3,50 140.000 140.000
2020-10-14 2020-10-13 4 Smith Devin Whittemore NERV Employee Stock Option (right to buy) A - Award D 3,50 85.000 85.000
2020-10-14 2020-10-13 4 Davidson Michael NERV Employee Stock Option (right to buy) A - Award D 3,50 85.000 85.000
2020-10-14 2020-10-13 4 Saoud Jay NERV Employee Stock Option (right to buy) A - Award D 3,50 100.000 100.000
2020-10-14 2020-10-13 4 Ahlholm Frederick W NERV Employee Stock Option (right to buy) A - Award D 3,50 85.000 85.000
2020-10-14 2020-10-13 4 Reilly Joseph H. NERV Employee Stock Option (right to buy) A - Award D 3,50 85.000 85.000
2020-09-11 2020-09-10 4 VAN HEEK G JAN NERV Common Stock P - Purchase D 2,9700 7.000 21 20.333
2020-08-17 2020-06-19 4 Smith Devin Whittemore NERV Employee Stock Option (right to buy) A - Award D 7,11 153.531 153.531
2020-08-17 2020-06-19 4 Race Geoff NERV Employee Stock Option (right to buy) A - Award D 7,11 275.568 275.568
2020-08-17 2020-06-19 4 Davidson Michael NERV Employee Stock Option (right to buy) A - Award D 7,11 137.784 137.784
2020-08-17 2020-06-19 4 Luthringer Remy NERV Employee Stock Option (right to buy) A - Award D 7,11 354.302 354.302
2020-08-17 2020-06-19 4 Reilly Joseph H. NERV Employee Stock Option (right to buy) A - Award D 7,11 153.531 153.531
2020-08-17 2020-06-19 4 Russell Richard E. NERV Employee Stock Option (right to buy) A - Award D 7,11 185.025 185.025
2020-08-17 2020-06-19 4 Saoud Jay NERV Employee Stock Option (right to buy) A - Award D 7,11 236.202 236.202
2020-08-17 2020-06-19 4 Ahlholm Frederick W NERV Employee Stock Option (right to buy) A - Award D 7,11 137.784 137.784
2020-06-12 2020-06-11 4 DOYLE WILLIAM F NERV Stock Option (right to buy) A - Award D 3,40 40.000 40.000
2020-06-12 2020-06-11 4 HASLER HANS PETER NERV Stock Option (right to buy) A - Award D 3,40 20.000 20.000
2020-06-12 2020-06-11 4 HILLEMAN JERYL L NERV Stock Option (right to buy) A - Award D 3,40 20.000 20.000
2020-06-12 2020-06-11 4 Kupfer David NERV Stock Option (right to buy) A - Award D 3,40 20.000 20.000
2020-06-12 2020-06-11 4 Laghrissi-Thode Fouzia NERV Stock Option (right to buy) A - Award D 3,40 20.000 20.000
2020-06-12 2020-06-11 4 VAN HEEK G JAN NERV Stock Option (right to buy) A - Award D 3,40 20.000 20.000
2020-05-27 2020-05-26 4 Ahlholm Frederick W NERV Common Stock S - Sale D 15,0000 -8.339 -125 6.884
2020-01-03 2019-12-31 4 Race Geoff NERV Employee Stock Option (right to buy) A - Award D 7,11 74.432 74.432
2020-01-03 2019-12-31 4 Reilly Joseph H. NERV Employee Stock Option (right to buy) A - Award D 7,11 41.469 41.469
2020-01-03 2019-12-31 4 Russell Richard E. NERV Employee Stock Option (right to buy) A - Award D 7,11 49.975 49.975
2020-01-03 2019-12-31 4 Saoud Jay NERV Employee Stock Option (right to buy) A - Award D 7,11 63.798 63.798
2020-01-03 2019-12-31 4 Smith Devin Whittemore NERV Employee Stock Option (right to buy) A - Award D 7,11 41.469 41.469
2020-01-03 2019-12-31 4 Ahlholm Frederick W NERV Employee Stock Option (right to buy) A - Award D 7,11 37.216 37.216
2020-01-03 2019-12-31 4 Davidson Michael NERV Employee Stock Option (right to buy) A - Award D 7,11 37.216 37.216
2020-01-03 2019-12-31 4 Luthringer Remy NERV Employee Stock Option (right to buy) A - Award D 7,11 95.698 95.698
2019-12-17 2019-12-17 4 Race Geoff NERV Common Stock S - Sale D 7,1000 -5.826 -41 205.044
2019-12-17 2019-12-14 4 Race Geoff NERV Restricted Stock Unit M - Exercise D -12.500 12.500
2019-12-17 2019-12-14 4 Race Geoff NERV Common Stock M - Exercise D 12.500 210.870
2019-12-17 2019-12-17 4 Reilly Joseph H. NERV Common Stock S - Sale D 7,1000 -2.724 -19 26.225
2019-12-17 2019-12-14 4 Reilly Joseph H. NERV Restricted Stock Unit M - Exercise D -8.750 8.750
2019-12-17 2019-12-14 4 Reilly Joseph H. NERV Common Stock M - Exercise D 8.750 28.949
2019-12-17 2019-12-17 4 Ahlholm Frederick W NERV Common Stock S - Sale D 7,1000 -1.557 -11 15.223
2019-12-17 2019-12-14 4 Ahlholm Frederick W NERV Restricted Stock Unit M - Exercise D -5.000 5.000
2019-12-17 2019-12-14 4 Ahlholm Frederick W NERV Common Stock M - Exercise D 5.000 16.780
2019-12-17 2019-12-17 4 Luthringer Remy NERV Common Stock S - Sale D 7,1000 -2.412 -17 49.040
2019-12-17 2019-12-14 4 Luthringer Remy NERV Restricted Stock Unit M - Exercise D -18.750 18.750
2019-12-17 2019-12-14 4 Luthringer Remy NERV Common Stock M - Exercise D 18.750 51.452
2019-12-13 2019-12-12 4 Russell Richard E. NERV Common Stock S - Sale D 7,4200 -3.113 -23 33.770
2019-07-01 2019-06-27 4 DOYLE WILLIAM F NERV Common Stock P - Purchase D 5,5000 3.500 19 26.111
2019-06-27 2019-06-26 4 Kupfer David NERV Common Stock P - Purchase D 5,5500 10.000 56 219.188
2019-06-27 2019-06-26 4 HASLER HANS PETER NERV Common Stock P - Purchase D 5,6000 10.000 56 10.000
2019-06-27 2019-06-26 4 HILLEMAN JERYL L NERV Common Stock P - Purchase D 5,2500 1.000 5 1.000
2019-06-27 2019-06-26 4 VAN HEEK G JAN NERV Common Stock P - Purchase D 5,3700 10.000 54 13.333
2019-06-26 2019-06-24 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 6,0144 -197.000 -1.185 3.899.189
2019-06-21 2019-06-20 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 4,3413 -33.575 -146 4.096.189
2019-06-21 2019-06-19 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 4,4425 -77.243 -343 4.129.764
2019-06-19 2019-06-18 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 4,4393 -49.675 -221 4.207.007
2019-06-19 2019-06-17 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 4,4487 -56.243 -250 4.256.682
2019-06-17 2019-06-14 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 4,4971 -25.169 -113 4.312.925
2019-06-17 2019-06-13 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 4,5133 -53.298 -241 4.338.094
2019-06-13 2019-06-12 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 4,5719 -26.901 -123 4.391.392
2019-06-13 2019-06-11 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 4,7769 -33.150 -158 4.418.293
2019-06-13 2019-06-12 4 DOYLE WILLIAM F NERV Stock option (right to buy) A - Award D 4,50 20.000 20.000
2019-05-31 2019-05-31 4 Kupfer David NERV Stock Option (right to buy) A - Award D 5,21 20.000 20.000
2019-05-31 2019-05-31 4 Laghrissi-Thode Fouzia NERV Stock Option (right to buy) A - Award D 5,21 20.000 20.000
2019-05-31 2019-05-31 4 VAN HEEK G JAN NERV Stock Option (right to buy) A - Award D 5,21 20.000 20.000
2019-05-31 2019-05-31 4 HILLEMAN JERYL L NERV Stock Option (right to buy) A - Award D 5,21 20.000 20.000
2019-05-31 2019-05-31 4 DOYLE WILLIAM F NERV Stock Option (right to buy) A - Award D 5,21 20.000 20.000
2019-05-31 2019-05-31 4 HASLER HANS PETER NERV Stock Option (right to buy) A - Award D 5,21 20.000 20.000
2019-05-21 2019-05-20 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 6,0750 -200 -1 4.451.443
2019-05-21 2019-05-17 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 6,0164 -22.718 -137 4.451.643
2019-05-16 2019-05-16 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 6,3715 -44.836 -286 4.474.361
2019-05-16 2019-05-15 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 6,6357 -53.418 -354 4.519.197
2019-05-16 2019-05-14 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 7,0548 -36.574 -258 4.572.615
2018-12-26 2018-12-20 4 DOYLE WILLIAM F NERV Common Stock P - Purchase D 6,5000 2.000 13 22.611
2018-12-18 2018-12-17 4 Reilly Joseph H. NERV Common Stock S - Sale D 7,4600 -2.728 -20 20.199
2018-12-18 2018-12-14 4 Reilly Joseph H. NERV Restricted Stock Unit M - Exercise D -8.750 17.500
2018-12-18 2018-12-14 4 Reilly Joseph H. NERV Common Stock M - Exercise D 8.750 22.927
2018-12-18 2018-12-17 4 Luthringer Remy NERV Common Stock S - Sale D 7,4600 -2.604 -19 32.702
2018-12-18 2018-12-14 4 Luthringer Remy NERV Restricted Stock Unit M - Exercise D -18.750 37.500
2018-12-18 2018-12-14 4 Luthringer Remy NERV Common Stock M - Exercise D 18.750 35.306
2018-12-18 2018-12-17 4 Ahlholm Frederick W NERV Common Stock S - Sale D 7,4600 -1.559 -12 11.780
2018-12-18 2018-12-14 4 Ahlholm Frederick W NERV Restricted Stock Unit M - Exercise D -5.000 10.000
2018-12-18 2018-12-14 4 Ahlholm Frederick W NERV Common Stock M - Exercise D 5.000 13.339
2018-12-18 2018-12-17 4 Race Geoff NERV Common Stock S - Sale D 7,4600 -5.999 -45 198.370
2018-12-18 2018-12-14 4 Race Geoff NERV Restricted Stock Unit M - Exercise D -12.500 25.000
2018-12-18 2018-12-14 4 Race Geoff NERV Common Stock M - Exercise D 12.500 204.369
2018-12-13 2018-12-12 4 Russell Richard E. NERV Common Stock S - Sale D 7,9600 -3.117 -25 36.883
2018-12-13 2018-12-11 4 Russell Richard E. NERV Employee Stock Option (right to buy) A - Award D 7,96 260.000 260.000
2018-12-13 2018-12-11 4 Saoud Jay NERV Employee Stock Option (right to buy) A - Award D 7,96 96.000 96.000
2018-12-13 2018-12-11 4 Smith Devin Whittemore NERV Employee Stock Option (right to buy) A - Award D 7,96 120.000 120.000
2018-12-13 2018-12-11 4 Ahlholm Frederick W NERV Employee Stock Option (right to buy) A - Award D 7,96 120.000 120.000
2018-12-13 2018-12-11 4 Davidson Michael NERV Employee Stock Option (right to buy) A - Award D 7,96 175.000 175.000
2018-12-13 2018-12-11 4 Luthringer Remy NERV Employee Stock Option (right to buy) A - Award D 7,96 410.000 410.000
2018-12-13 2018-12-11 4 Race Geoff NERV Employee Stock Option (right to buy) A - Award D 7,96 175.000 175.000
2018-12-13 2018-12-11 4 Reilly Joseph H. NERV Employee Stock Option (right to buy) A - Award D 7,96 120.000 120.000
2018-12-12 2018-12-11 4 DOYLE WILLIAM F NERV Common Stock P - Purchase D 7,9500 4.000 32 20.611
2018-12-12 2018-12-10 4 DOYLE WILLIAM F NERV Common Stock P - Purchase D 8,0000 2.000 16 16.611
2018-11-21 2018-11-20 4 DOYLE WILLIAM F NERV Common Stock P - Purchase D 8,2000 2.000 16 14.611
2018-10-15 2018-10-11 4 DOYLE WILLIAM F NERV Common Stock P - Purchase D 10,0000 600 6 12.611
2018-10-03 2018-10-01 4 Reilly Joseph H. NERV Employee Stock Option (Right to Buy) M - Exercise D 5,19 -10.000 47.524
2018-10-03 2018-10-01 4 Reilly Joseph H. NERV Employee Stock Option (Right to Buy) M - Exercise D 4,71 -15.000 27.400
2018-10-03 2018-10-01 4 Reilly Joseph H. NERV Common Stock S - Sale D 12,6200 -1.700 -21 14.177
2018-10-03 2018-10-01 4 Reilly Joseph H. NERV Common Stock S - Sale D 12,0200 -23.300 -280 15.877
2018-10-03 2018-10-01 4 Reilly Joseph H. NERV Common Stock M - Exercise D 5,1900 10.000 52 39.177
2018-10-03 2018-10-01 4 Reilly Joseph H. NERV Common Stock M - Exercise D 4,7100 15.000 71 29.177
2018-10-03 2018-10-01 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 12,3509 -15.444 -191 4.609.189
2018-10-01 2018-09-28 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 12,6151 -34.589 -436 4.624.633
2018-10-01 2018-09-27 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 12,5702 -31.684 -398 4.659.222
2018-09-19 2018-09-17 4 DOYLE WILLIAM F NERV Common Stock P - Purchase D 10,5000 1.800 19 12.011
2018-09-17 2018-09-14 4 DOYLE WILLIAM F NERV Common Stock P - Purchase D 10,5000 200 2 10.211
2018-09-17 2018-09-13 4 DOYLE WILLIAM F NERV Common Stock P - Purchase D 10,5000 2.000 21 10.011
2018-09-11 2018-09-11 4 DOYLE WILLIAM F NERV Common Stock P - Purchase D 9,7200 4.011 39 8.011
2018-09-11 2018-09-10 4 DOYLE WILLIAM F NERV Common Stock P - Purchase D 9,8800 4.000 40 4.000
2018-08-24 2018-08-23 4 Reilly Joseph H. NERV Employee Stock Option (Right to Buy) M - Exercise D 4,71 -25.000 42.400
2018-08-24 2018-08-23 4 Reilly Joseph H. NERV Common Stock S - Sale D 10,0000 -25.000 -250 14.177
2018-08-24 2018-08-23 4 Reilly Joseph H. NERV Common Stock M - Exercise D 4,7100 25.000 118 39.177
2018-08-02 2018-08-01 4 Smith Devin Whittemore NERV Employee Stock Option (Righ to Buy) A - Award D 7,95 200.000 200.000
2018-08-02 2018-08-01 4 DOYLE WILLIAM F NERV Stock Option (Right to Buy) A - Award D 7,95 20.000 20.000
2018-07-17 2018-07-16 4 HILLEMAN JERYL L NERV Stock Option (Right to Buy) A - Award D 8,20 40.000 40.000
2018-06-11 2018-06-07 4 VAN HEEK G JAN NERV Stock Option (Right to Buy) A - Award D 8,25 20.000 20.000
2018-06-11 2018-06-07 4 DOYLE WILLIAM F NERV Stock Option (Right to Buy) A - Award D 8,25 20.000 20.000
2018-06-11 2018-06-07 4 HASLER HANS PETER NERV Stock Option (Right to Buy) A - Award D 8,25 20.000 20.000
2018-06-11 2018-06-07 4 Kupfer David NERV Stock Option (Right to Buy) A - Award D 8,25 20.000 20.000
2018-06-11 2018-06-07 4 Laghrissi-Thode Fouzia NERV Stock Option (Right to Buy) A - Award D 8,25 20.000 20.000
2018-02-02 2018-01-31 4 Beer Marc D NERV Stock Option (Right to Buy) A - Award D 10,20 12.500 12.500
2018-02-02 2018-01-31 4 Beer Marc D NERV Stock Option (Right to Buy) A - Award D 10,00 12.500 12.500
2018-02-02 2018-01-31 4 Beer Marc D NERV Stock Option (Right to Buy) D - Sale to Issuer D 10,00 -12.500 0
2018-02-02 2018-01-31 4 Beer Marc D NERV Stock Option (Right to Buy) D - Sale to Issuer D 10,20 -12.500 0
2018-02-02 2018-01-31 4 Beer Marc D NERV Stock Option (Right to Buy) A - Award D 4,34 7.500 7.500
2018-02-02 2018-01-31 4 Beer Marc D NERV Stock Option (Right to Buy) D - Sale to Issuer D 4,34 -7.500 0
2018-02-02 2018-01-31 4 Beer Marc D NERV Stock Option (Right to Buy) A - Award D 6,00 127.513 127.513
2018-02-02 2018-01-31 4 Beer Marc D NERV Stock Option (Right to Buy) D - Sale to Issuer D 6,00 -127.513 0
2018-02-02 2018-01-31 4 Beer Marc D NERV Stock Option (Right to Buy) A - Award D 9,49 80.356 80.356
2018-02-02 2018-01-31 4 Beer Marc D NERV Stock Option (Right to Buy) D - Sale to Issuer D 9,49 -80.356 0
2018-01-04 2018-01-02 4 Luthringer Remy NERV Employee Stock Option (Right to Buy) A - Award D 6,20 200.000 200.000
2017-12-15 2017-12-14 4 Race Geoff NERV Restricted Stock Unit M - Exercise D -12.500 37.500
2017-12-15 2017-12-14 4 Race Geoff NERV Common Stock S - Sale D 5,7900 -5.829 -34 191.869
2017-12-15 2017-12-14 4 Race Geoff NERV Common Stock M - Exercise D 12.500 197.698
2017-12-15 2017-12-13 4 Race Geoff NERV Employee Stock Option (Right to Buy) A - Award D 6,10 200.000 200.000
2017-12-15 2017-12-13 4 Saoud Jay NERV Employee Stock Option (Right to Buy) A - Award D 6,10 175.000 175.000
2017-12-15 2017-12-13 4 Davidson Michael NERV Employee Stock Option (Right to Buy) A - Award D 6,10 125.000 125.000
2017-12-15 2017-12-14 4 Ahlholm Frederick W NERV Restricted Stock Unit M - Exercise D -5.000 15.000
2017-12-15 2017-12-14 4 Ahlholm Frederick W NERV Common Stock S - Sale D 5,8000 -1.661 -10 8.339
2017-12-15 2017-12-14 4 Ahlholm Frederick W NERV Common Stock M - Exercise D 5.000 10.000
2017-12-15 2017-12-13 4 Ahlholm Frederick W NERV Employee Stock Option (Right to Buy) A - Award D 6,10 120.000 120.000
2017-12-15 2017-12-14 4 Reilly Joseph H. NERV Restricted Stock Unit M - Exercise D -8.750 26.250
2017-12-15 2017-12-14 4 Reilly Joseph H. NERV Common Stock S - Sale D 5,8000 -2.906 -17 14.177
2017-12-15 2017-12-14 4 Reilly Joseph H. NERV Common Stock M - Exercise D 8.750 17.083
2017-12-15 2017-12-13 4 Reilly Joseph H. NERV Employee Stock Option (Right to Buy) A - Award D 6,10 120.000 120.000
2017-12-15 2017-12-14 4 Luthringer Remy NERV Restricted Stock Unit M - Exercise D -18.750 56.250
2017-12-15 2017-12-14 4 Luthringer Remy NERV Common Stock S - Sale D 5,8500 -2.194 -13 16.556
2017-12-15 2017-12-14 4 Luthringer Remy NERV Common Stock M - Exercise D 18.750 18.750
2017-12-15 2017-12-13 4 Luthringer Remy NERV Employee Stock Option (Right to Buy) A - Award D 6,10 350.000 350.000
2017-12-12 2017-12-10 4 DOYLE WILLIAM F NERV Option Grant (Right to Buy) A - Award D 5,70 40.000 40.000
2017-12-12 2017-12-10 4 HASLER HANS PETER NERV Option Grant (Right to Buy) A - Award D 5,70 40.000 40.000
2017-12-12 2017-12-11 4 Russell Richard E. NERV Employee Stock option (Right to Buy) A - Award D 6,05 775.000 775.000
2017-12-12 2017-12-11 4 Russell Richard E. NERV Common Stock A - Award D 40.000 40.000
2017-09-14 2017-08-29 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. NERV Common Stock J - Other I 0,0001 -3.892.256 -0 0
2017-09-05 2017-09-01 4 Saoud Jay NERV Employee Stock Option (Right to Buy) A - Award D 6,45 100.000 100.000
2017-07-26 2017-07-24 4 Vandervelpen Nico NERV Stock Option (Right to Buy) A - Award D 10,20 12.500 12.500
2017-07-26 2017-07-24 4 Vandervelpen Nico NERV Stock Option (Right to Buy) A - Award D 10,00 12.500 12.500
2017-07-26 2017-07-24 4 Vandervelpen Nico NERV Stock Option (Right to Buy) D - Sale to Issuer D 10,00 -12.500 0
2017-07-26 2017-07-24 4 Vandervelpen Nico NERV Stock Option (Right to Buy) D - Sale to Issuer D 10,20 -12.500 0
2017-07-26 2017-07-24 4 Vandervelpen Nico NERV Stock Option (Right to Buy) A - Award D 4,71 25.000 25.000
2017-07-26 2017-07-24 4 Vandervelpen Nico NERV Stock Option (Right to Buy) D - Sale to Issuer D 4,71 -25.000 0
2017-06-05 2017-06-01 4 VAN HEEK G JAN NERV Stock Option (Right to Buy) A - Award D 10,00 12.500 12.500
2017-06-05 2017-06-01 4 Vandervelpen Nico NERV Stock Option (Right to Buy) A - Award D 10,00 12.500 12.500
2017-06-05 2017-06-01 4 Ahlholm Frederick W NERV Employee Stock Option (Right to Buy) M - Exercise D 4,71 -7.250 49.750
2017-06-05 2017-06-01 4 Ahlholm Frederick W NERV Employee Stock Option (Right to Buy) M - Exercise D 5,19 -14.381 43.143
2017-06-05 2017-06-01 4 Ahlholm Frederick W NERV Common Stock S - Sale D 11,0000 -10.381 -114 5.000
2017-06-05 2017-06-01 4 Ahlholm Frederick W NERV Common Stock S - Sale D 10,0000 -11.250 -112 15.381
2017-06-05 2017-06-01 4 Ahlholm Frederick W NERV Common Stock M - Exercise D 4,7100 7.250 34 26.631
2017-06-05 2017-06-01 4 Ahlholm Frederick W NERV Common Stock M - Exercise D 5,1900 14.381 75 19.381
2017-06-05 2017-06-01 4 Laghrissi-Thode Fouzia NERV Stock Option (Right to Buy) A - Award D 10,00 12.500 12.500
2017-06-05 2017-06-01 4 Kupfer David NERV Stock Option (Right to Buy) A - Award D 10,00 12.500 12.500
2017-06-05 2017-06-01 4 Levine Mark S. NERV Employee Stock Option (Right to Buy) M - Exercise D 5,19 -17.500 39.774
2017-06-05 2017-06-01 4 Levine Mark S. NERV Common Stock S - Sale D 11,0000 -17.500 -192 0
2017-06-05 2017-06-01 4 Levine Mark S. NERV Common Stock M - Exercise D 5,1900 17.500 91 17.500
2017-06-05 2017-06-01 4 Beer Marc D NERV Stock Option (Right to Buy) A - Award D 10,00 12.500 12.500
2017-03-21 2017-03-20 4 Beer Marc D NERV Common Stock P - Purchase D 7,8900 25.000 197 50.000
2017-03-21 2017-03-17 4 Beer Marc D NERV Common Stock P - Purchase D 8,3400 25.000 208 25.000
2017-02-07 2017-02-06 4 Luthringer Remy NERV Stock Option (Right to Buy) M - Exercise D 4,71 -2.185 285.719
2017-02-07 2017-02-06 4 Luthringer Remy NERV Common Stock S - Sale D 11,0000 -2.185 -24 0
2017-02-07 2017-02-06 4 Luthringer Remy NERV Common Stock M - Exercise D 4,7100 2.185 10 2.185
2017-02-07 2017-02-03 4 Luthringer Remy NERV Stock Option (Right to Buy) M - Exercise D 4,71 -32.096 287.904
2017-02-07 2017-02-03 4 Luthringer Remy NERV Common Stock S - Sale D 11,0200 -32.096 -354 0
2017-02-07 2017-02-03 4 Luthringer Remy NERV Common Stock M - Exercise D 4,7100 32.096 151 32.096
2017-02-07 2017-02-06 4 Race Geoff NERV Common Stock S - Sale D 11,0000 -1.692 -19 185.198
2017-02-07 2017-02-03 4 Race Geoff NERV Common Stock S - Sale D 11,0200 -19.758 -218 186.890
2017-01-13 2017-01-11 4 Reilly Joseph H. NERV Stock Option (Right to Buy) M - Exercise D 4,71 -1.600 67.400
2017-01-13 2017-01-11 4 Reilly Joseph H. NERV Common Stock S - Sale D 12,0300 -1.600 -19 8.333
2017-01-13 2017-01-11 4 Reilly Joseph H. NERV Common Stock M - Exercise D 4,7100 1.600 8 9.933
2017-01-06 2017-01-04 4 Levine Mark S. NERV Stock Option (Right to Buy) M - Exercise D 5,19 -250 57.274
2017-01-06 2017-01-04 4 Levine Mark S. NERV Stock Option (Right to Buy) M - Exercise D 4,71 -17.250 51.750
2017-01-06 2017-01-04 4 Levine Mark S. NERV Common Stock S - Sale D 12,0000 -17.500 -210 0
2017-01-06 2017-01-04 4 Levine Mark S. NERV Common Stock M - Exercise D 5,1900 250 1 17.500
2017-01-06 2017-01-04 4 Levine Mark S. NERV Common Stock M - Exercise D 4,7100 17.250 81 17.250
2017-01-05 2017-01-03 4 Davidson Michael NERV Stock Option (Right to Buy) A - Award D 11,75 145.000 145.000
2016-12-29 2016-12-27 4 Ahlholm Frederick W NERV Employee Stock Option (Right to Buy) M - Exercise D 4,71 -12.000 57.000
2016-12-29 2016-12-27 4 Ahlholm Frederick W NERV Common Stock S - Sale D 12,5100 -17.000 -213 5.000
2016-12-29 2016-12-27 4 Ahlholm Frederick W NERV Common Stock M - Exercise D 4,7100 12.000 57 22.000
2016-12-20 3 Davidson Michael NERV Common Stock D 0
2016-12-16 2016-12-14 4 Ahlholm Frederick W NERV Employee Stock Option (Right to Buy) A - Award D 13,45 35.000 35.000
2016-12-16 2016-12-14 4 Ahlholm Frederick W NERV Restricted Stock Unit A - Award D 20.000 20.000
2016-12-16 2016-12-14 4 Race Geoff NERV Employee Stock Option (Right to Buy) A - Award D 13,45 100.000 100.000
2016-12-16 2016-12-14 4 Race Geoff NERV Restricted Stock Unit A - Award D 50.000 50.000
2016-12-16 2016-12-14 4 Luthringer Remy NERV Stock Option (Right to Buy) A - Award D 13,45 150.000 150.000
2016-12-16 2016-12-14 4 Luthringer Remy NERV Restricted Stock Unit A - Award D 75.000 75.000
2016-12-16 2016-12-14 4 Reilly Joseph H. NERV Employee Stock Option (Right to Buy) A - Award D 13,45 60.000 60.000
2016-12-16 2016-12-14 4 Reilly Joseph H. NERV Restricted Stock Unit A - Award D 35.000 35.000
2016-12-16 2016-12-14 4 Levine Mark S. NERV Employee Stock Option (Right to Buy) A - Award D 13,45 35.000 35.000
2016-12-16 2016-12-14 4 Levine Mark S. NERV Restricted Stock Units A - Award D 20.000 20.000
2016-12-14 2016-12-12 4 Ollier Michele See Footnotes NERV Warrant Shares X - Other I 5,77 -202.634 0
2016-12-14 2016-12-12 4 Ollier Michele See Footnotes NERV Common Stock X - Other I 5,7720 202.634 1.170 4.690.906
2016-12-14 2016-12-12 4 De Rubertis Francesco See Footnotes NERV Warrant Shares X - Other I 5,77 -202.634 0
2016-12-14 2016-12-12 4 De Rubertis Francesco See Footnotes NERV Common Stock X - Other I 5,7720 202.634 1.170 4.690.906
2016-12-14 2016-12-12 4 Index Venture Associates III Ltd See Footnotes NERV Warrant Shares X - Other I 5,77 -202.634 0
2016-12-14 2016-12-12 4 Index Venture Associates III Ltd See Footnotes NERV Common Stock X - Other I 5,7720 202.634 1.170 4.690.906
2016-08-12 2016-08-10 4 Ollier Michele See Footnotes NERV Common Stock S - Sale I 10,0000 -1.000.000 -10.000 4.488.272
2016-08-12 2016-08-10 4 De Rubertis Francesco See Footnotes NERV Common Stock S - Sale I 10,0000 -1.000.000 -10.000 4.488.272
2016-08-12 2016-08-10 4 Index Venture Associates III Ltd See Footnotes NERV Common Stock S - Sale I 10,0000 -1.000.000 -10.000 4.488.272
2016-06-21 2016-06-21 4 Kupfer David By wife NERV Common Stock P - Purchase I 10,7250 27.935 300 27.935
2016-06-21 2016-06-20 4 Kupfer David NERV Common Stock P - Purchase D 10,9530 27.700 303 209.188
2016-06-17 2016-06-16 4 Beer Marc D NERV Stock Option (right to buy) A - Award D 10,20 12.500 12.500
2016-06-17 2016-06-16 4 VAN HEEK G JAN NERV Stock Option (right to buy) A - Award D 10,20 12.500 12.500
2016-06-17 2016-06-16 4 Vandervelpen Nico NERV Stock Option (right to buy) A - Award D 10,20 12.500 12.500
2016-06-17 2016-06-16 4 Laghrissi-Thode Fouzia NERV Stock Option (right to buy) A - Award D 10,20 12.500 12.500
2016-06-17 2016-06-16 4 Kupfer David NERV Stock Option (right to buy) A - Award D 10,20 12.500 12.500
2016-03-18 2016-03-17 4 Kupfer David NERV Common Stock P - Purchase D 5,5100 181.488 1.000 181.488
2016-02-12 2015-03-18 5 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. NERV Common Stock P - Purchase I 4,9300 607.903 2.997 3.892.256
2015-12-08 2015-12-04 4 Levine Mark S. NERV Stock Option (right to buy) A - Award D 4,71 69.000 69.000
2015-12-08 2015-12-04 4 Reilly Joseph H. NERV Stock Option (right to buy) A - Award D 4,71 69.000 69.000
2015-12-08 2015-12-04 4 Race Geoff NERV Stock Option (right to buy) A - Award D 4,71 175.000 175.000
2015-12-08 2015-12-04 4 Luthringer Remy NERV Stock Option (right to buy) A - Award D 4,71 320.000 320.000
2015-12-08 2015-12-04 4 Ahlholm Frederick W NERV Stock Option (right to buy) A - Award D 4,71 69.000 69.000
2015-12-08 2015-12-04 4 Vandervelpen Nico NERV Stock Option (right to buy) A - Award D 4,71 25.000 25.000
2015-11-03 3 Kupfer David NERV Common Stock D 0
2015-11-03 3 Kupfer David NERV Common Stock D 0
2015-11-03 2015-11-02 4 Kupfer David NERV Stock Option (right to buy) A - Award D 5,41 25.000 25.000
2015-06-18 2015-06-17 4 Laghrissi-Thode Fouzia NERV Stock Option (right to buy) A - Award D 25.000 25.000
2015-05-18 3 Laghrissi-Thode Fouzia NERV Common Stock D 0
2015-04-16 2015-02-02 4/A Beer Marc D NERV Stock Option (right to buy) A - Award D 7.500 7.500
2015-04-16 2015-04-14 4 Ahlholm Frederick W NERV Stock Option (right to buy) A - Award D 5,19 57.524 57.524
2015-04-16 2015-04-14 4 Race Geoff NERV Stock Option (right to buy) A - Award D 5,19 213.133 213.133
2015-04-16 2015-04-14 4 Luthringer Remy NERV Stock Option (right to buy) A - Award D 5,19 399.623 399.623
2015-04-16 2015-04-14 4 Reilly Joseph H. NERV Stock Option (right to buy) A - Award D 5,19 57.524 57.524
2015-04-16 2015-04-14 4 Levine Mark S. NERV Stock Option (right to buy) A - Award D 5,19 57.524 57.524
2015-03-20 2015-03-18 4 De Rubertis Francesco See Footnotes NERV Warrant Shares P - Purchase I 5,77 0,1250 202.634 25 202.634
2015-03-20 2015-03-18 4 De Rubertis Francesco See Footnotes NERV Common Stock P - Purchase I 4,8100 202.634 975 5.488.272
2015-03-20 2015-03-18 4 Care Capital III LLC NERV Common Stock S - Sale I 6,2500 -6.700 -42 1.662.592
2015-03-20 2015-03-18 4 Care Capital III LLC NERV Common Stock S - Sale I 5,7500 -1.200.000 -6.900 1.669.292
2015-03-20 2015-03-18 4 Ollier Michele See Footnotes NERV Warrant Shares P - Purchase I 5,77 0,1250 202.634 25 202.634
2015-03-20 2015-03-18 4 Ollier Michele See Footnotes NERV Common Stock P - Purchase I 4,8100 202.634 975 5.488.272
2015-03-20 2015-03-18 4 Index Venture Associates III Ltd See Footnotes NERV Warrant Shares P - Purchase I 5,77 0,1250 202.634 25 202.634
2015-03-20 2015-03-18 4 Index Venture Associates III Ltd See Footnotes NERV Common Stock P - Purchase I 4,8100 202.634 975 5.488.272
2015-03-17 2015-03-13 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation- JJDC, Inc. NERV Warrants (right to buy) P - Purchase I 5,77 0,1250 607.903 76 607.903
2015-03-17 2015-03-13 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. NERV Common Stock P - Purchase I 4,8100 607.903 2.924 4.500.159
2015-02-04 2015-02-02 4 VAN HEEK G JAN NERV Stock Option (right to buy) A - Award D 7.500 7.500
2015-02-04 2015-02-02 4 Beer Marc D NERV Stock Option (right to buy) A - Award D 7.500 7.500
2015-01-26 2015-01-26 4 Care Capital III LLC NERV Common Stock S - Sale I 5,0200 -23.111 -116 2.869.292
2015-01-26 2015-01-23 4 Care Capital III LLC NERV Common Stock S - Sale I 5,1400 -63.304 -325 2.892.403
2015-01-26 2015-01-22 4 Care Capital III LLC NERV Common Stock S - Sale I 5,1100 -395.697 -2.022 2.955.707
2015-01-08 2015-01-08 4 Care Capital III LLC NERV Common Stock S - Sale I 5,6600 -70.659 -400 3.351.404
2015-01-08 2015-01-07 4 Care Capital III LLC NERV Common Stock S - Sale I 5,8500 -64.278 -376 3.422.063
2015-01-08 2015-01-06 4 Care Capital III LLC NERV Common Stock S - Sale I 7,9400 -396.871 -3.151 3.486.341
2014-09-03 2014-09-02 4 Levine Mark S. NERV Employee Stock Option (Right to Buy) A - Award D 7,10 93.541 93.541
2014-09-03 3 Vandervelpen Nico NERV No securities are beneficially owned. D 0
2014-07-17 3 Johnson & Johnson Innovation - JJDC, Inc. By Johnson & Johnson Development Corporation NERV Common Stock I 6.568.706
2014-07-17 3 Johnson & Johnson Innovation - JJDC, Inc. By Johnson & Johnson Development Corporation NERV Common Stock I 6.568.706
2014-07-17 3 Johnson & Johnson Innovation - JJDC, Inc. By Johnson & Johnson Development Corporation NERV Common Stock I 6.568.706
2014-07-11 2014-06-30 4 Luthringer Remy NERV Employee Stock Option (Right to Buy) A - Award D 6,00 207.869 649.842
2014-07-11 2014-06-30 4 Luthringer Remy NERV Employee Stock Option (Right to Buy) A - Award D 6,00 441.973 441.973
2014-07-09 2014-06-30 4 Beer Marc D NERV Stock Option (Right to Buy) A - Award D 6,00 127.513 127.513
2014-07-09 2014-07-01 4 VAN HEEK G JAN NERV Common Stock P - Purchase D 6,0000 3.333 20 3.333
2014-07-09 2014-06-30 4 VAN HEEK G JAN NERV Stock Option (Right to Buy) A - Award D 6,00 51.967 51.967
2014-07-09 2014-07-07 4 Ollier Michele See Footnotes NERV Convertible Promissory Note C - Conversion I 6,00 6,0000 -61.922 -372 0
2014-07-09 2014-07-07 4 Ollier Michele See Footnotes NERV Convertible Promissory Note C - Conversion I 6,00 6,0000 -114.077 -684 0
2014-07-09 2014-07-07 4 Ollier Michele See Footnotes NERV Common Stock P - Purchase I 6,0000 333.333 2.000 5.285.638
2014-07-09 2014-07-07 4 Ollier Michele See Footnotes NERV Common Stock P - Purchase I 6,0000 1.287.500 7.725 4.952.305
2014-07-09 2014-07-07 4 Ollier Michele See Footnotes NERV Common Stock C - Conversion I 6,0000 61.922 372 3.664.805
2014-07-09 2014-07-07 4 Ollier Michele See Footnotes NERV Common Stock C - Conversion I 6,0000 114.077 684 3.602.883
2014-07-09 2014-07-01 4 Ahlholm Frederick W NERV Common Stock P - Purchase D 6,0000 10.000 60 10.000
2014-07-09 2014-06-30 4 Ahlholm Frederick W NERV Employee Stock Option (Right to Buy) A - Award D 6,00 93.541 93.541
2014-07-09 2014-07-07 4 Care Capital III LLC See footnotes NERV Convertible Promissory Note C - Conversion I 6,00 6,0000 -61.923 -372 0
2014-07-09 2014-07-07 4 Care Capital III LLC See footnotes NERV Convertible Promissory Note C - Conversion I 6,00 6,0000 -114.078 -684 0
2014-07-09 2014-07-07 4 Care Capital III LLC See footnotes NERV Common Stock P - Purchase I 6,0000 737.500 4.425 3.883.212
2014-07-09 2014-07-07 4 Care Capital III LLC See footnotes NERV Common Stock C - Conversion I 6,0000 61.923 372 3.145.712
2014-07-09 2014-07-07 4 Care Capital III LLC See footnotes NERV Common Stock C - Conversion I 6,0000 114.078 684 3.083.789
2014-07-09 2014-07-07 4 De Rubertis Francesco See footnotes NERV Convertible Promissory Note C - Conversion I 6,00 6,0000 -61.922 -372 0
2014-07-09 2014-07-07 4 De Rubertis Francesco See footnotes NERV Convertible Promissory Note C - Conversion I 6,00 6,0000 -114.077 -684 0
2014-07-09 2014-07-07 4 De Rubertis Francesco See footnotes NERV Common Stock P - Purchase I 6,0000 333.333 2.000 5.285.638
2014-07-09 2014-07-07 4 De Rubertis Francesco See footnotes NERV Common Stock P - Purchase I 6,0000 1.287.500 7.725 4.952.305
2014-07-09 2014-07-07 4 De Rubertis Francesco See footnotes NERV Common Stock C - Conversion I 6,0000 61.922 372 3.664.805
2014-07-09 2014-07-07 4 De Rubertis Francesco See footnotes NERV Common Stock C - Conversion I 6,0000 114.077 684 3.602.883
2014-07-09 2014-07-01 4 Vivaldi Coelho Rogerio NERV Common Stock P - Purchase D 6,0000 41.667 250 41.667
2014-07-09 2014-06-30 4 Vivaldi Coelho Rogerio NERV Employee Stock Option (right to buy) A - Award D 6,00 498.621 498.621
2014-07-09 2014-07-01 4 Race Geoff NERV Common Stock P - Purchase D 6,0000 33.333 200 206.648
2014-07-09 2014-06-30 4 Race Geoff NERV Employee Stock Option (Right to Buy) A - Award D 6,00 249.442 346.585
2014-07-09 2014-06-30 4 Race Geoff NERV Employee Stock Option (Right to Buy) A - Award D 6,00 97.143 97.143
2014-07-09 2014-07-01 4 Reilly Joseph H. NERV Common Stock P - Purchase D 6,0000 8.333 50 8.333
2014-07-09 2014-06-30 4 Reilly Joseph H. NERV Employee Stock Option (Right to Buy) A - Award D 6,00 93.541 93.541
2014-07-09 2014-07-07 4 Pellegrini Lorenzo See footnotes NERV Convertible Promissory Note C - Conversion I 6,00 6,0000 -61.923 -372 0
2014-07-09 2014-07-07 4 Pellegrini Lorenzo See footnotes NERV Convertible Promissory Note C - Conversion I 6,00 6,0000 -114.078 -684 0
2014-07-09 2014-07-07 4 Pellegrini Lorenzo See footnotes NERV Common Stock P - Purchase I 6,0000 737.500 4.425 3.883.212
2014-07-09 2014-07-07 4 Pellegrini Lorenzo See footnotes NERV Common Stock C - Conversion I 6,0000 61.923 372 3.145.712
2014-07-09 2014-07-07 4 Pellegrini Lorenzo See footnotes NERV Common Stock C - Conversion I 6,0000 114.078 684 3.083.789
2014-07-09 2014-07-07 4 Index Venture Associates III Ltd See footnotes NERV Convertible Promissory Note C - Conversion I 6,00 6,0000 -61.922 -372 0
2014-07-09 2014-07-07 4 Index Venture Associates III Ltd See footnotes NERV Convertible Promissory Note C - Conversion I 6,00 6,0000 -114.077 -684 0
2014-07-09 2014-07-07 4 Index Venture Associates III Ltd See footnotes NERV Common Stock P - Purchase I 6,0000 333.333 2.000 5.285.638
2014-07-09 2014-07-07 4 Index Venture Associates III Ltd See footnotes NERV Common Stock P - Purchase I 6,0000 1.287.500 7.725 4.952.305
2014-07-09 2014-07-07 4 Index Venture Associates III Ltd See footnotes NERV Common Stock C - Conversion I 6,0000 61.922 372 3.664.805
2014-07-09 2014-07-07 4 Index Venture Associates III Ltd See footnotes NERV Common Stock C - Conversion I 6,0000 114.077 684 3.602.883
2014-06-30 3 Ollier Michele See Footnotes NERV Common Stock I 6.873.796
2014-06-30 3 Ollier Michele See Footnotes NERV Common Stock I 6.873.796
2014-06-30 3 Care Capital Offshore Investments III LP See Footnotes NERV Common Stock I 5.939.422
2014-06-30 3 Care Capital Offshore Investments III LP See Footnotes NERV Common Stock I 5.939.422
2014-06-30 3 Care Capital Offshore Investments III LP See Footnotes NERV Common Stock I 5.939.422
2014-06-30 3 Care Capital Offshore Investments III LP See Footnotes NERV Common Stock I 5.939.422
2014-06-30 3 De Rubertis Francesco See Footnotes NERV Common Stock I 6.873.796
2014-06-30 3 De Rubertis Francesco See Footnotes NERV Common Stock I 6.873.796
2014-06-30 3 Race Geoff NERV Common Stock D 346.630
2014-06-30 3 Race Geoff NERV Common Stock D 346.630
2014-06-30 3 Luthringer Remy By Wint2felden Holding SA NERV Common Stock I 1.853.208
2014-06-30 3 Luthringer Remy By Wint2felden Holding SA NERV Common Stock I 1.853.208
2014-06-30 3 Pellegrini Lorenzo See Footnotes NERV Common Stock I 5.939.422
2014-06-30 3 Pellegrini Lorenzo See Footnotes NERV Common Stock I 5.939.422
2014-06-30 3 Index Venture Associates V Ltd See Footnotes NERV Common Stock I 6.873.796
2014-06-30 3 Index Venture Associates V Ltd See Footnotes NERV Common Stock I 6.873.796
2014-06-30 3 Index Venture Associates V Ltd See Footnotes NERV Common Stock I 6.873.796
2014-06-30 3 Index Venture Associates V Ltd See Footnotes NERV Common Stock I 6.873.796
2014-06-30 3 Index Venture Associates V Ltd See Footnotes NERV Common Stock I 6.873.796
P
Offener Markt oder privater Kauf von nicht-derivativen oder derivativen Wertpapieren
S
Freiverkauf oder privater Verkauf von nicht-derivativen oder derivativen Wertpapieren
A
Gewährung, Vergabe oder sonstiger Erwerb von Wertpapieren des Unternehmens (z. B. eine Option)
C
Umwandlung von Derivaten
D
Verkauf oder Rückübertragung von Wertpapieren an das Unternehmen
F
Zahlung des Ausübungspreises oder der Steuerschuld mit einem Teil der vom Unternehmen erhaltenen Wertpapiere
G
Schenkung von Wertpapieren durch oder an den Insider
K
Aktien-Swaps und ähnliche Absicherungstransaktionen
M
Ausübung oder Umwandlung eines vom Unternehmen erhaltenen derivativen Wertpapiers (z. B. einer Option)
V
Eine freiwillig auf Formular 4 gemeldete Transaktion
J
Sonstige (mit einer Fußnote zur Beschreibung der Transaktion)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:4MNA 3,98 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista